Associated Papers
Impact of pharmacogenetics on aspirin resistance: a systematic review.
Silva GFD et al.
Arquivos De Neuro-psiquiatria, 2023
Use of genetic data to guide therapy in arterial disease.
Ross S et al.
Journal of Thrombosis and Haemostasis : Jth, 2015
Genetic polymorphisms of HO-1 and COX-1 are associated with aspirin resistance defined by light transmittance aggregation in Chinese Han patients.
Li XL et al.
Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/hemostasis, 2013
Association of single nucleotide polymorphisms on Interleukin 17 receptor A (IL17RA) gene with aspirin hypersensitivity in asthmatics.
Park JS et al.
Human Immunology, 2013
Platelet gene polymorphisms and risk of bleeding in patients undergoing elective coronary angiography: a genetic substudy of the PRAGUE-8 trial.
Motovska Z et al.
Atherosclerosis, 2010
Aspirin-induced peptic ulcer and genetic polymorphisms.
Shiotani A et al.
Journal of Gastroenterology and Hepatology, 2010
The preventive factors for aspirin-induced peptic ulcer: aspirin ulcer and corpus atrophy.
Shiotani A et al.
Journal of Gastroenterology, 2009
Effect of a specific cyclooxygenase-gene polymorphism (A-842G/C50T) on the occurrence of peptic ulcer hemorrhage.
van Oijen MG et al.
Digestive Diseases and Sciences, 2006
Cyclooxygenase-1 gene polymorphisms in patients with different asthma phenotypes and atopy.
Shi J et al.
The European Respiratory Journal, 2005
Genetic variation in cyclooxygenase 1: effects on response to aspirin.
Halushka MK et al.
Clinical Pharmacology and Therapeutics, 2003
Cyclooxygenase 1 (COX1) polymorphisms in African-American and Caucasian populations.
Ulrich CM et al.
Human Mutation, 2002
Select a paper to view details